Meeting
2016 ASCO Annual Meeting
Bcl-2 family pro-death and pro-survival proteins in Ph-like B cell precursor acute lymphoblastic leukemia.
Authors
Muhammad Omair Kamal
Loma Linda University Medical Center, Loma Linda, CA
Muhammad Omair Kamal , Cornelia Stoian , Shania Aponte-Paris , Micheal Brandon Reed , Hannah Choi , Jacquelyn Coats , Evgeny Chirshev , Chien-Shing Chen , Kimberly J Payne
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant
Track
Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant
Sub Track
Acute Leukemia
Citation
J Clin Oncol 34, 2016 (suppl; abstr 7030)
DOI
10.1200/JCO.2016.34.15_suppl.7030
Abstract #
7030
Poster Bd #
22
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Mechanism of biologic therapy for pre B-cell acute lymphoblastic leukemia with CRLF2 overexpression.
First Author: WayAnne Watson
Poster
2019 ASCO Annual Meeting
A phase I trial of palbociclib in combination with dexamethasone in relapsed or refractory adult B-cell acute lymphoblastic leukemia (ALL).
First Author: Margaret T. Kasner
Poster
2024 ASCO Annual Meeting
A single-cell multiomics analysis of IRF4 in mediating treatment resistance in ibrutinib-treated chronic lymphocytic leukemia (CLL).
First Author: Alina S. Gerrie
Poster
2023 ASCO Breakthrough
Clinical applications of measurable residual disease monitoring by multi-parametric flow cytometry and next-generation sequencing in B-cell precursor acute lymphoblastic leukemia.
First Author: Gun-Dong Lee